Platelet count, previous infection and FCGR2B genotype predict development of chronic disease in newly diagnosed idiopathic thrombocytopenia in childhood: Results of a prospective study

British Journal of Haematology

Volumn 127, Issue 5, 2004, Pages 561-567

  Bruin, Marrie ^a   Bierings, Marc ^a   Uiterwaal, Cuno ^b   Révész, Tom ^a   Bode, Lonneke ^a   Wiesman, Marie Elize ^a   Kuijpers, Taco ^c   Tamminga, Rienk ^d   De Haas, Masja ^c,e  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

^e SANQUIN RESEARCH   (Netherlands)

Author keywords

Childhood; FCGR2B; Idiopathic thrombocytopenia

Indexed keywords

CORTICOSTEROID; FC GAMMA RECEPTOR IIB; FC RECEPTOR; IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FCGR2B GENE; FEMALE; GENE; GENOTYPE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOMODULATION; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; THROMBOCYTE COUNT;

ADOLESCENT; AUTOANTIBODIES; BLOOD PLATELETS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; GENOTYPE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOTHERAPY; INFANT; LOGISTIC MODELS; MALE; PLATELET COUNT; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RECEPTORS, IGG; RECURRENCE; THROMBOCYTOPENIA; THROMBOPOIETIN;

EID: 10344253785     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05235.x     Document Type: Article

References (23)

1. Blanchette, V. (2002) Childhood chronic immune thrombocytopenic purpura (ITP). Blood Reviews, 16, 23-26.
2. Blanchette, V.S. & Price, V. (2003) Childhood chronic immune thrombocytopenic purpura: unresolved issues. Journal of Pediatric Hematology/Oncology, 25(suppl. 1), S28-S33.
3. Bolton-Maggs, P. (2003) Severe bleeding in idiopathic thrombocytopenic purpura. Journal of Pediatric Hematology/Oncology, 25(suppl. 1), S47-S51.
4. Carcao, M.D., Blanchette, V.S., Wakefield, C.D., Stephens, D., Ellis, J., Matheson, K. & Denomme, G.A. (2003) Fcgamma receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura. British Journal of Haematology, 120, 135-141.
5. Crow, A.R. & Lazarus, A.H. (2003) Role of Fcgamma receptors in the pathogenesis and treatment of idiopathic thrombocytopenic purpura. Journal of Pediatric Hematology/Oncology, 25(suppl. 1), S14-S18.
6. Eden, O.B. & Lilleyman, J.S. (1992) Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group. Archives of Disease in Childhood, 67, 1056-1058.
7. Folman, C.C., dem Bome, A.E., Rensink, I.H., Gerritsen, W., van der School, C.E., de Haas, M. & Aarden, L. (1997) Sensitive measurement of thrombopoietin by a monoclonal antibody based sandwich enzyme-linked immunosorbent assay. Thrombosis and Haemostasis, 78, 1262-1267.
8. Foster, C.B., Zhu, S., Erichsen, H.C., Lehrnbecher, T., Hart, E.S., Choi, E., Stein, S., Smith, M.W., Steinberg, S.M., Imbach, P., Kuhne, T. & Chanock, S.J. (2001) Polymorphisms in inflammatory cytokines and Fcgamma receptors in childhood chronic immune thrombocytopenic purpura: a pilot study. British Journal of Haematology, 113, 596-599.
9. George, J.N., Woolf, S.H., Raskob, G.E., Wasser, J.S., Aledort, L.M., Ballern, P.J., Blanchette, V.S., Bussel, J.B., Cines, D.B., Kelton, J.G., Lichtin, A.E., McMillan, R., Okerbloom, J.A., Regan, D.H. & Warrier, I. (1996) Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood, 88, 3-40.
10. de Haas, M., Kleijer, M., van Zwieten, R., Roos, D. & von dem Borne, A.E. (1995) Neutrophil Fc gamma RIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families. Blood, 86, 2403-2413.
11. Imbach, P. (1991) Immune thrombocytopenic purpura and intravenous immunoglobulin. Cancer, 68(Suppl. 6), 1422-1425.
12. Koene, H.R., Kleijer, M., Algra, J., Roos, D., von dem Borne, A.E. & de Haas, M. (1997) Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype. Blood, 90, 1109-1114.
13. Kuhne, T. (2003) Investigation and management of newly diagnosed childhood idiopathic thrombocytopenic purpura: problems and proposed solutions. Journal of Pediatric Hematology/Oncology, 25(suppl. 1), S24-S27.
14. Kuhne, T., Imbach, P., Bolton-Maggs, P.H., Berchtold, W., Blanchette, V. & Buchanan, G.R. (2001) Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet, 358, 2122-2125.
15. Kuhne, T., Buchanan, G.R., Zimmerman, S., Michaels, L.A., Kohan, R., Berchtold, W., Imbach, P. & Intercontinental Childhood ITP Study Group (2003) A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. Journal of Pediatrics, 143, 605-608.
16. Kyogoku, C., Dijstelbloem, H.M., Tsuchiya, N., Hatta, Y., Kato, H., Yamaguchi, A., Fukazawa, T., Jansen, M.D., Hashimoto, H., van de Winkel, J.G., Kallenberg, C.G. & Tokunaga, K. (2002) Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis and Rheumatism, 46, 1242-1254.
17. Li, X., Wu, J., Carter, R.H., Edberg, J.C., Su, K., Cooper, G.S. & Kimberly, R.P. (2003) A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling. Arthritis and Rheumatism, 48, 3242-3252.
18. van den Oudenrijn, S., Bruin, M., Folman, C.C., Bussel, J., de Haas, M. & von dem Borne, A.E. (2002) Three parameters, plasma thrombopoietin levels, plasma glycocalicin levels and megakaryocyte culture , distinguish between different causes of congenital thrombocytopenia. British Journal of Haematology, 117, 390-398.
19. Porcelijn, L., Folman, C.C., Bossers, B., Huiskes, E., Overbeeke, M.A., School, C.E., de Haas, M. & von dem Borne, A.E. (1998) The diagnostic value of thrombopoietin level measurements in thrombocytopenia. Thrombosis and Haemostasis, 79, 1101-1105.
20. Ravetch, J.V. & Lanier, L.L. (2000) Immune inhibitory receptors. Science, 290, 84-89.
21. Rosthoj, S., Hedlund-Treutiger, I., Rajantie, J., Zeller, B., Jonsson, O.G., Blinder, G., Wesenberg, F. & Henter, J.I. (2003) Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: A prospective Nordic study of an unselected cohort. Journal of Pediatrics, 143, 302-307.
22. Samuelsson, A., Towers, T.L. & Ravetch, J.V. (2001) Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science, 291, 484-486.
23. Von dem Borne, A.E., Verheugt, F.W., Oosterhof, F., von Riesz, E., de la Riviere, A.B. & Engelfriet, C.P. (1978) A simple immunofluorescence test for the detection of platelet antibodies. British Journal of Haematology, 39, 195-207.